Role of circulating-tumor DNA analysis in non-small cell lung cancer

被引:75
作者
Jiang, Tao [1 ]
Ren, Shengxiang [1 ]
Zhou, Caicun [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai 200433, Peoples R China
关键词
Non-small-cell lung cancer; Cell free DNA; Circulating-tumor DNA; FACTOR RECEPTOR MUTATIONS; EGFR MUTATIONS; PLASMA DNA; SERUM DNA; PERIPHERAL-BLOOD; MICROSATELLITE ALTERATIONS; PROGNOSTIC-SIGNIFICANCE; NONINVASIVE DETECTION; CLINICAL-SIGNIFICANCE; PROMOTER METHYLATION;
D O I
10.1016/j.lungcan.2015.09.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The discovery of actionable driver mutations such as epidermal growth factor receptor (EGFR) and microtubule-associated protein-like 4 anaplastic lymphoma kinase (EML4-ALK) and their highly responses to EGFR and ALK tyrosine kinase inhibitors (TKIs) in patients with advanced non-small-cell lung cancer (NSCLC) allowed precise medicine into reality. However, a substantial part of patients still have no sufficient tissue to perform genomic analysis. As a promising noninvasive biomarker and potential surrogate for the entire tumor genome, circulating tumor DNA (ctDNA) has been applied to the detection of driver gene mutations and epigenetic alteration and monitoring of tumor burden, acquired resistance, tumor heterogeneity and early diagnosis. Since precise therapy is a strategy that optimal therapy is decided based on simultaneous tumor genome information, ctDNA, as a liquid biopsy, may help to perform dynamic genetic surveillance. In this paper we will perspectively discuss the biology and identification of ctDNA in the blood of NSCLC patients and its clinical applications in patient management. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 104 条
[1]   Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer [J].
Alama, Angela ;
Truini, Anna ;
Coco, Simona ;
Genova, Carlo ;
Grossi, Francesco .
DRUG DISCOVERY TODAY, 2014, 19 (10) :1671-1676
[2]  
[Anonymous], CANCER
[3]   Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer [J].
Bai, Hua ;
Wang, Zhijie ;
Chen, Keneng ;
Zhao, Jun ;
Lee, J. Jack ;
Wang, Shuhang ;
Zhou, Qinghua ;
Zhuo, Minglei ;
Mao, Li ;
An, Tongtong ;
Duan, Jianchun ;
Yang, Lu ;
Wu, Meina ;
Liang, Zhen ;
Wang, Yuyan ;
Kang, Xiaozheng ;
Wang, Jie .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3077-3083
[4]   Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non-Small-Cell Lung Cancer [J].
Bai, Hua ;
Mao, Li ;
Wang, Hang Shu ;
Zhao, Jun ;
Yang, Lu ;
An, Tong Tong ;
Wang, Xin ;
Duan, Chun Jian ;
Wu, Na Mei ;
Guo, Zhi Qing ;
Liu, Yi Xu ;
Liu, Hong Ning ;
Wang, Ye Yu ;
Wang, Jie .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) :2653-2659
[5]   Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer [J].
Beaver, Julia A. ;
Jelovac, Danijela ;
Balukrishna, Sasidharan ;
Cochran, Rory L. ;
Croessmann, Sarah ;
Zabransky, Daniel J. ;
Wong, Hong Yuen ;
Toro, Patricia Valda ;
Cidado, Justin ;
Blair, Brian G. ;
Chu, David ;
Burns, Timothy ;
Higgins, Michaela J. ;
Stearns, Vered ;
Jacobs, Lisa ;
Habibi, Mehran ;
Lange, Julie ;
Hurley, Paula J. ;
Lauring, Josh ;
VanDenBerg, Dustin A. ;
Kessler, Jill ;
Jeter, Stacie ;
Samuels, Michael L. ;
Maar, Dianna ;
Cope, Leslie ;
Cimino-Mathews, Ashley ;
Argani, Pedram ;
Wolff, Antonio C. ;
Park, Ben Ho .
CLINICAL CANCER RESEARCH, 2014, 20 (10) :2643-2650
[6]   CIRCULATING DNA AS A POSSIBLE FACTOR IN ONCOGENESIS [J].
BENDICH, A ;
WILCZOK, T ;
BORENFREUND, E .
SCIENCE, 1965, 148 (3668) :374-+
[7]   Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies [J].
Bettegowda, Chetan ;
Sausen, Mark ;
Leary, Rebecca J. ;
Kinde, Isaac ;
Wang, Yuxuan ;
Agrawal, Nishant ;
Bartlett, Bjarne R. ;
Wang, Hao ;
Luber, Brandon ;
Alani, Rhoda M. ;
Antonarakis, Emmanuel S. ;
Azad, Nilofer S. ;
Bardelli, Alberto ;
Brem, Henry ;
Cameron, John L. ;
Lee, Clarence C. ;
Fecher, Leslie A. ;
Gallia, Gary L. ;
Gibbs, Peter ;
Le, Dung ;
Giuntoli, Robert L. ;
Goggins, Michael ;
Hogarty, Michael D. ;
Holdhoff, Matthias ;
Hong, Seung-Mo ;
Jiao, Yuchen ;
Juhl, Hartmut H. ;
Kim, Jenny J. ;
Siravegna, Giulia ;
Laheru, Daniel A. ;
Lauricella, Calogero ;
Lim, Michael ;
Lipson, Evan J. ;
Marie, Suely Kazue Nagahashi ;
Netto, George J. ;
Oliner, Kelly S. ;
Olivi, Alessandro ;
Olsson, Louise ;
Riggins, Gregory J. ;
Sartore-Bianchi, Andrea ;
Schmidt, Kerstin ;
Shih, Ie-Ming ;
Oba-Shinjo, Sueli Mieko ;
Siena, Salvatore ;
Theodorescu, Dan ;
Tie, Jeanne ;
Harkins, Timothy T. ;
Veronese, Silvio ;
Wang, Tian-Li ;
Weingart, Jon D. .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)
[8]   Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma [J].
Bidard, Francois-Clement ;
Madic, Jordan ;
Mariani, Pascale ;
Piperno-Neumann, Sophie ;
Rampanou, Aurore ;
Servois, Vincent ;
Cassoux, Nathalie ;
Desjardins, Laurence ;
Milder, Maud ;
Vaucher, Isabelle ;
Pierga, Jean-Yves ;
Lebofsky, Ronald ;
Stern, Marc-Henri ;
Lantz, Olivier .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (05) :1207-1213
[9]   Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors [J].
Brevet, Marie ;
Johnson, Melissa L. ;
Azzoli, Christopher G. ;
Ladanyi, Marc .
LUNG CANCER, 2011, 73 (01) :96-102
[10]   The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients [J].
Camps, Carlos ;
Jantus-Lewintre, Eloisa ;
Cabrera, Andrea ;
Blasco, Ana ;
Sanmartin, Elena ;
Gallach, Sandra ;
Caballero, Cristina ;
del Pozo, Nieves ;
Rosell, Rafael ;
Guijarro, Ricardo ;
Sirera, Rafael .
LUNG CANCER, 2011, 72 (03) :365-369